Lipid profile, haemostatic variables and angiographically-defined coronary artery disease: A cross-sectional study in an Irish population

[1]  M. Mancini,et al.  Serum apolipoproteins, lipoproteins and fatty acids in relation to ischaemic heart disease in northern and southern European males. , 2009, Acta medica Scandinavica.

[2]  A. Hamsten.  Apolipoproteins, dyslipoproteinaemia and premature coronary heart disease. , 2009, Acta medica Scandinavica.

[3]  J. Buring,et al.  Decreased HDL2 and HDL3 Cholesterol, Apo A‐I and Apo A‐II, and Increased Risk of Myocardial Infarction , 1992, Circulation.

[4]  Shcherbakova Ia,et al.  [Comparative evaluation of nutrition of healthy persons, patients with the preclinical stage of ischemic heart disease and in patients with marked coronary disease]. , 1991 .

[5]  P. Wilson,et al.  Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease. , 1991, The American journal of cardiology.

[6]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[7]  C. Rackley,et al.  Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. , 1991, The American journal of cardiology.

[8]  R. Goldberg,et al.  Correlates of Atherosclerosis in Coronary Arteries of Patients Undergoing Angiographic Evaluation , 1990, Angiology.

[9]  J. Sasaki,et al.  Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. , 1989, Atherosclerosis.

[10]  L. Hunt,et al.  APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE , 1988, The Lancet.

[11]  S. Thompson,et al.  Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis. , 1988, British heart journal.

[12]  R. D'Agostino,et al.  Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. , 1987, American heart journal.

[13]  V. Armstrong,et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.

[14]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[15]  S. Thompson,et al.  HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.

[16]  Gerald S. Berenson,et al.  Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study , 1986 .

[17]  Lippincott Williams Wilkins,et al.  Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. , 1983, Circulation.

[18]  M. Gotsman,et al.  Cardiovascular risk factor clustering and ratio of total cholesterol to high-density lipoprotein cholesterol in angiographically documented coronary artery disease. , 1991, The American journal of cardiology.

[19]  H. Wasir,et al.  Profile of coronary artery disease in Indian women: correlation of clinical, non invasive and coronary angiographic findings. , 1991, Indian heart journal.

[20]  J. Tuomilehto,et al.  WHO MONICA Project: assessing CHD mortality and morbidity. , 1989, International journal of epidemiology.

[21]  Cass Principal Investigators and Their Associates.  Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Comparability of entry characteristics and survival in randomized patients and nonrandomized patients meeting randomization criteria. , 1984, Journal of the American College of Cardiology.